Extraction and preconcentration of salbutamol and terbutaline from aqueous samples using hollow fiber supported liquid membrane containing anionic carrier

被引:92
作者
Yamini, Yadollah
Reimann, Curt T.
Vatanara, Alireza
Jonsson, Jan Ake
机构
[1] Lund Univ, Dept Analyt Chem, S-22100 Lund, Sweden
[2] Tarbiat Modares Univ, Dept Chem, Tehran, Iran
[3] Univ Tehran Med Sci, Dept Pharmaceut, Sch Pharm, Tehran, Iran
关键词
three-phase LPME; hollow fiber membranes; salbutamol; terbutaline; HPLC-MS; water analysis; urine;
D O I
10.1016/j.chroma.2006.05.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This paper presents a new three-phase liquid-phase microextraction (LPME) strategy for extraction and preconcentration of salbutamol (SB) and terbutaline (TB) from aqueous samples, including urine. The drugs were extracted from I I ml of aqueous sample (source phase; SP) into an organic phase with microliter volume located inside the pores of a polypropylene hollow fiber, and then back-extracted into 24 mu l of a second aqueous solution as the receiving phase (RP), located in the lumen of the hollow fiber. In preliminary experiments, we tried to transport the drugs using a pH gradient between the two sides of the hollow fiber. Due to the existence of both amine and phenolic groups on the drugs, very little transport occurred and enrichment factors (EF) less than one were obtained. Further experiments were done in the presence of bis(2-ethylhexyl) monohydrogenphosphoric acid (D2EHPA) or methyltrioctylammonium chloride (Aliquat 336) in the organic phase, to extract drugs from acidic and basic matrices, respectively. Results showed that transport of drugs from alkaline solution into I M of sodium bromide occurred when the membrane was impregnated with dihexyl ether containing 20% Aliquat 336. To optimize the EF, the effects of different parameters such as the nature of organic solvent used to impregnate the membrane, compositions and volumes of SP and RP, type and concentration of carrier, extraction time and stirring rate were investigated. Optimal results were obtained in the presence of 0.005 M of NaOH (pH 11.70) in the SP, I M of NaBr in the RP, 20% of Aliquat 336 in dihexyl ether as membrane impregnation solvent, stirring rate of 500 rpm and extraction time of 60 min. Under these conditions. enrichment factors of 52.9 and 213.1, dynamic linear ranges of 20-5000 and 10-5000, and limits of detection of 2.5 and 0.5 ng/ml were obtained for salbutamol and terbutaline, respectively. Also determination of drugs in environmental water and urine samples in the range of nanograms per millilitre with RSDs < 10% was possible using HPLC-photodiode array detection or HPLC-MS. (c) 2006 Elsevier B.V. All fights reserved.
引用
收藏
页码:57 / 67
页数:11
相关论文
共 61 条
[1]   Electrochemical determination of pharmaceuticals in spiked water samples [J].
Ambrosi, A ;
Antiochia, R ;
Campanella, L ;
Dragone, R ;
Lavagnini, I .
JOURNAL OF HAZARDOUS MATERIALS, 2005, 122 (03) :219-225
[2]   Analytical methodology for enantiomers of salbutamol in human urine for application in doping control [J].
Bergés, R ;
Segura, J ;
de la Torre, X ;
Ventura, R .
JOURNAL OF CHROMATOGRAPHY B, 1999, 723 (1-2) :173-184
[3]  
Bergés R, 2000, CLIN CHEM, V46, P1365
[4]  
Biancotto G, 1999, J MASS SPECTROM, V34, P1346, DOI 10.1002/(SICI)1096-9888(199912)34:12<1346::AID-JMS893>3.0.CO
[5]  
2-#
[6]   Determination of clenbuterol in bovine liver by combining matrix solid phase dispersion and molecularly imprinted solid phase extraction followed by liquid chromatography/electrospray ion trap multiple stage mass spectrometry [J].
Crescenzi, C ;
Bayoudh, S ;
Cormack, PAG ;
Klein, T ;
Ensing, K .
ANALYTICAL CHEMISTRY, 2001, 73 (10) :2171-2177
[7]  
Damasceno L, 2000, J MASS SPECTROM, V35, P1285, DOI 10.1002/1096-9888(200011)35:11<1285::AID-JMS61>3.0.CO
[8]  
2-L
[9]   Determination of terbutaline sulfate and its degradation products in pharmaceutical formulations using LC [J].
Daraghmeh, N ;
Al-Omari, MM ;
Sara, Z ;
Badwan, AA ;
Jaber, AMY .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 29 (05) :927-937
[10]  
De Wasch K, 1998, ANALYST, V123, P2701, DOI 10.1039/a805039b